Detalhe da pesquisa
1.
Simultaneous pharmacokinetic modeling of unbound and total darunavir with ritonavir in adolescents: a substudy of the SMILE trial.
Antimicrob Agents Chemother
; 68(2): e0100423, 2024 Feb 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-38092664
2.
Continued attendance in a PrEP program despite low adherence and non-protective drug levels among adolescent girls and young women in Kenya: Results from a prospective cohort study.
PLoS Med
; 19(9): e1004097, 2022 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-36095005
3.
Nucleoside/nucleotide reverse transcriptase inhibitor sparing regimen with once daily integrase inhibitor plus boosted darunavir is non-inferior to standard of care in virologically-suppressed children and adolescents living with HIV - Week 48 results of the randomised SMILE Penta-17-ANRS 152 clinical trial.
EClinicalMedicine
; 60: 102025, 2023 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-37304494
4.
Youth-friendly services and a mobile phone application to promote adherence to pre-exposure prophylaxis among adolescent men who have sex with men and transgender women at-risk for HIV in Thailand: a randomized control trial.
J Int AIDS Soc
; 23 Suppl 5: e25564, 2020 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-32869511
5.
Pharmacokinetics of rilpivirine and 24-week outcomes after switching from efavirenz in virologically suppressed HIV-1-infected adolescents.
Antivir Ther
; 23(3): 259-265, 2018.
Artigo
em Inglês
| MEDLINE | ID: mdl-28994660
6.
Brief Report: AIDS-Defining Events and Deaths in HIV-Infected Children and Adolescents on Antiretrovirals: A 14-Year Study in Thailand.
J Acquir Immune Defic Syndr
; 77(1): 17-22, 2018 01 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-29040162
7.
Weekends-off efavirenz-based antiretroviral therapy in HIV-infected children, adolescents and young adults (BREATHER): Extended follow-up results of a randomised, open-label, non-inferiority trial.
PLoS One
; 13(4): e0196239, 2018.
Artigo
em Inglês
| MEDLINE | ID: mdl-29684092
8.
Pharmacokinetics of Darunavir/Ritonavir With Etravirine Both Twice Daily in Human Immunodeficiency Virus-Infected Adolescents and Young Adults.
J Pediatric Infect Dis Soc
; 6(3): 294-296, 2017 Sep 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-27103489
9.
Pharmacokinetics of Once-Daily Darunavir/Ritonavir With and Without Etravirine in Human Immunodeficiency Virus-Infected Children, Adolescents, and Young Adults.
J Pediatric Infect Dis Soc
; 5(2): 131-7, 2016 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-27199469
10.
Rilpivirine Pharmacokinetics Without and With Darunavir/Ritonavir Once Daily in Adolescents and Young Adults.
Pediatr Infect Dis J
; 35(9): e271-4, 2016 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-27187753
11.
Pharmacokinetics of Unboosted Atazanavir in Treatment-experienced HIV-infected Children, Adolescents and Young Adults.
Pediatr Infect Dis J
; 35(12): 1333-1335, 2016 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-27583590